Fredrik Lindberg
CEO
Born 1957. Appointed in Nov 2014
Education: MD, Ph.D, and an Associate Professor of Clinical Pharmacology.

Fredrik has extensive experience from the life science industry and from growth companies with international operations. Previous positions include CEO of Bone Support AB, Nordic Medical Director of Searle Pharmaceuticals, and Head of the Department of Clinical Pharmacology at the University Hospital in Lund. Member of Enzymatica’s Board 2012-feb 2015.

Ulf Blom
EVP Marketing & Operations

Born 1965. With Enzymatica since 2011.
Education: B.Sc. Economics and Business Administration.

Co-founder of Enzymatica. Ulf has over 15 years experience in various management positions in sales and marketing in the pharmaceutical industry, including Novo Nordisk, Astra Zeneca and ALK. Has extensive experience in all phases of strategic global commercialization of pharmaceutical products.

Bengt Jöndell
acting CFO
Assumed his position on April 4th, 2016
Education: Bachelor of Science, Business Administration and Management, Master of Science, Chemical Engineering

Bengt's most recent post was as CFO and Administrative Manager at BTJ Group AB. Before that, his appointments included Senior Financial Advisor at the med tech company, BoneSupport, CFO/Administrative Manager at Inpac, Business Controller at Pharmacia & Upjohn Consumer Healthcare, Pharmacia Consumer Pharma and Kabi Pharmacia Nicorette.

Anna Isaksson
VP Quality and Regulatory Management
Born 1973. With Enzymatica since 2015
Education: M.Sc. Industrial Engineering. Chalmers University of Technology.

Anna has over 15 years working experience in international Medtech companies such as, Gambro and ArjoHuntleigh. She has extensive experience in both product development and quality management, including management positions in these areas.

Claus Egstrand
Chief Commercial Officer
Born 1961. With Enzymatica since August 2017

Claus Egstrand's previous positions have included being Head of Europe for MSD Consumer Care in the pharmaceutical company Merck & Co, Vice President, General Manager Medsurg Europe in the medical device company Stryker Corporation,

Senior Vice President Consumer Healthcare for Latin America, Africa, Asia, Japan and Australia in the pharmaceutical company Pfizer, Vice President and head of global marketing for the smoking cessation product Nicorette in the pharmaceutical company Pharmacia and CEO of the Johnson&Johnson/Merck Pharmaceuticals' operation in France. He joins Enzymatica from a position as Group President, International at HOLOGIC CORP.

Johan Lindvall
Chief Operating Officer
Born 1970. With Enzymatica since October 2017
Education: Bachelor of Science Mechanical Engineering ( LTH )

One of Johan Lindvall’s previous positions was as Supply Chain Director for the Nordic countries in Biomet, with responsibility for logistics and customer service. Biomet, now Zimmer Biomet, is a world-leading orthopaedic company.

Johan Lindvall has also been Plant Director and had assignments in European operations for Biomet. He joins Enzymatica from a position as Deputy CEO and Chief Operating Office of Agellis Group, which develops, manufactures and markets measuring instruments and monitoring equipment for the global metal industry.

Johan Lindvall has previously held senior positions in supply chain and product development in companies such as Volvo Excavators AB and Precise Biometrics AB.

This content needs to be approved before viewing.
Yes, I accept
No, I decline